Literature DB >> 32271385

Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent.

Guillaume Grzych1,2, Luisa Vonghia3,4, Marie-Adélaïde Bout2, Jonas Weyler3,4, An Verrijken4,5, Eveline Dirinck4,5, Marie Joncquel Chevalier Curt2, Luc Van Gaal4,5, Réjane Paumelle1, Sven Francque3,4, Anne Tailleux1, Joel T Haas1, Bart Staels1,2.   

Abstract

CONTEXT: Plasma branched chain amino acid (BCAA) concentrations correlate positively with body mass index (BMI), measures of insulin resistance (IR), and severity of nonalcoholic fatty liver disease (NAFLD). Moreover, plasma BCAA concentrations also differ between the sexes, which display different susceptibilities to cardio-metabolic diseases.
OBJECTIVE: Assess whether plasma BCAA concentrations associate with NAFLD severity independently of BMI, IR, and sex. PATIENTS: Patients visiting the obesity clinic of the Antwerp University Hospital were consecutively recruited from 2006 to 2014. DESIGN AND
SETTING: A cross-sectional study cohort of 112 obese patients (59 women and 53 men) was divided into 4 groups according to NAFLD severity. Groups were matched for sex, age, BMI, homeostatic model assessment of IR, and hemoglobin A1c. MAIN OUTCOME MEASURES: Fasting plasma BCAA concentrations were measured by tandem mass spectrometry using the aTRAQ™ method.
RESULTS: In the study cohort, a modest positive correlation was observed between plasma BCAA concentrations and NAFLD severity, as well as a strong effect of sex on plasma BCAA levels. Subgroup analysis by sex revealed that while plasma BCAA concentrations increased with severity of NAFLD in women, they tended to decrease in men. Additionally, only women displayed significantly increased plasma BCAAs with increasing fibrosis.
CONCLUSION: Plasma BCAA concentrations display sex-dimorphic changes with increasing severity of NAFLD, independently of BMI, IR, and age. Additionally, plasma BCAA are associated with significant fibrosis in women, but not in men. These results highlight the importance of a careful consideration of sex as a major confounding factor in cross-sectional studies of NAFLD. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32271385     DOI: 10.1210/clinem/dgaa175

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Insights Into Metabolic Mechanisms and Their Application in the Treatment of NASH.

Authors:  Phillip J White; Manal F Abdelmalek
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

2.  Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease.

Authors:  Émilie Gobeil; Ina Maltais-Payette; Nele Taba; Francis Brière; Nooshin Ghodsian; Erik Abner; Jérôme Bourgault; Eloi Gagnon; Hasanga D Manikpurage; Christian Couture; Patricia L Mitchell; Patrick Mathieu; François Julien; Jacques Corbeil; Marie-Claude Vohl; Sébastien Thériault; Tõnu Esko; André Tchernof; Benoit J Arsenault
Journal:  Metabolites       Date:  2022-05-13

Review 3.  Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research.

Authors:  Amedeo Lonardo; Ayako Suzuki
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 4.  Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling.

Authors:  Sara Della Torre
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

5.  Multi-omics profiling: the way towards precision medicine in metabolic diseases.

Authors:  Cheng Hu; Weiping Jia
Journal:  J Mol Cell Biol       Date:  2021-08-18       Impact factor: 6.216

Review 6.  Nonalcoholic fatty liver disease shows significant sex dimorphism.

Authors:  Xing-Yu Chen; Cong Wang; Yi-Zhou Huang; Li-Li Zhang
Journal:  World J Clin Cases       Date:  2022-02-16       Impact factor: 1.337

7.  Porphyromonas gingivalis Induces Increases in Branched-Chain Amino Acid Levels and Exacerbates Liver Injury Through livh/livk.

Authors:  Leng Wu; Rui Shi; Huimin Bai; Xingtong Wang; Jian Wei; Chengcheng Liu; Yafei Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-03-10       Impact factor: 5.293

Review 8.  The Emerging Role of Branched-Chain Amino Acids in Liver Diseases.

Authors:  Emily Kwun Kwan Lo; Jing-Hang Xu; Qiao Zhan; Zheng Zeng; Hani El-Nezami
Journal:  Biomedicines       Date:  2022-06-18

9.  Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity.

Authors:  Thomas Grenier-Larouche; Lydia Coulter Kwee; Yann Deleye; Paola Leon-Mimila; Jacquelyn M Walejko; Robert W McGarrah; Simon Marceau; Sylvain Trahan; Christine Racine; André C Carpentier; Aldons J Lusis; Olga Ilkayeva; Marie-Claude Vohl; Adriana Huertas-Vazquez; André Tchernof; Svati H Shah; Christopher B Newgard; Phillip J White
Journal:  JCI Insight       Date:  2022-08-08

Review 10.  Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease.

Authors:  Anne Fougerat; Alexandra Montagner; Nicolas Loiseau; Hervé Guillou; Walter Wahli
Journal:  Cells       Date:  2020-07-08       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.